Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fluoroquinolones: Is Another FDA Safety Step Needed?

Nov 05 2015

• By Derrick Gingery

Related Content

Fluoroquinolones To Get “Better” But Not Necessarily Stronger Warning On Nerve Damage

Aug 16 2013

FDAAA Fading? REMS Use Continues To Decline As Drug Safety Law Matures

May 12 2014

Fluoroquinolone REMS Will Survey Patients, Doctors on Understanding of Risk

Jul 14 2008

Related Companies

Bayer AG

Johnson & Johnson

Additional Topics

United States Advisory Committees Safety BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window